Asmerom Amine sold $300K of CHYM

Asmerom Amine (Chief Accounting Officer) sold 10,000 shares of Chime Financial, Inc. (CHYM) at $30.00 ($0.30M total) on 2026-08-06 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Asmerom Amine
Published Aug 10, 2026, 11:32 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 10, 2026, 11:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CHYM
Neutral
high confidence
Mentioned
$CHYM
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CHYMNeutralLow
01

Why it matters

The newest disclosed fact is the CFO’s open-market sale of 10,000 shares at $30.00/share on 2026-08-06, reported via a pre-arranged 10b5-1 plan.

02

Market read

Traders may note the planned insider sale, but there is no accompanying fundamental catalyst in the text.

03

What to watch

The transaction size and 10b5-1 structure reduce interpretability; without context on total insider holdings, sale frequency, or concurrent corporate events, the signal is weak.

Relevance 3/10Novelty 2/10Timing: Filed on 2026-08-10 after the 2026-08-06 sale date.

Background

The article is an SEC Form 4 insider transaction filing for Chime Financial, Inc. (CHYM).

Company-level read

Ticker impact

$CHYMNeutralHigh confidence
Context

Chime Financial CFO Asmerom Amine sold 10,000 shares in an open-market transaction for about $300,000 under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move solely from this Form 4 sale; any impact is likely short-lived and sentiment-driven.

Evidence & confidence

The filing is an SEC Form 4 insider transaction, explicitly tied to a pre-arranged Rule 10b5-1 plan, and provides no new company-specific operational or financial information.

Market effects

No clear sector read-through because the disclosure is a single planned insider sale without new guidance or regulatory developments.

None indicated.

None indicated.

Counterpoint

Some traders may still treat insider selling as a mild negative sentiment input, especially if multiple insiders sell around the same period, even when 10b5-1 is used.

Key entities

  • Chime Financial, Inc.

    Subject of the Form 4 insider transaction disclosure (CHYM).

  • Asmerom Amine

    Chief Accounting Officer who executed the planned open-market sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CHYMHigh

Why is Chime Financial stock climbing today?

Chime Financial (CHYM) stock rose 2.8% in pre-market trading ahead of its inclusion in the S&P MidCap 400 index. Analysts raised price targets, with an average recommendation of 'Buy'. Q3 revenue grew 32% to $718M, and guidance was increased. The stock's gain contrasts with broader market declines.

$CHYMMed

Wells Fargo raises Chime Financial price target on strong results

Wells Fargo raised its price target for Chime Financial (CHYM) to $42.00 from $39.00, citing strong Q3 results and improved 2026 guidance. The company's revenue grew 26% with an 89% gross profit margin, though it remains unprofitable with an EPS of -$0.05. Chime's stock has gained 56% over the past year, trading at $29.87 with a market cap of $11.31 billion. The firm expects the Stride acquisition to close in early 2027, generating $100 million in annual synergies.

$CHYMHighAI 8/10

B.Riley raises Chime Financial stock price target on strong results

B.Riley raised its price target on Chime Financial (NASDAQ:CHYM) to $45.00, citing strong Q3 2026 results. Revenue was $718M, adjusted EBITDA $137M, both exceeding estimates. The company reported GAAP profitability for the third straight quarter, with net income of $44M. Active members reached 10.9M, and management raised full-year guidance. CHYM stock is up 56% over the past year, trading at $29.87.